A detailed history of Pensionmark Financial Group, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Pensionmark Financial Group, LLC holds 1,097 shares of UTHR stock, worth $404,562. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,097
Previous 388,464 99.72%
Holding current value
$404,562
Previous $139 Million 99.72%
% of portfolio
0.01%
Previous 0.77%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 25, 2024

SELL
$311.04 - $363.55 $120 Million - $141 Million
-387,367 Reduced 99.72%
1,097 $393,000
Q3 2024

Nov 14, 2024

BUY
$311.04 - $363.55 $121 Million - $141 Million
388,464 New
388,464 $139 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.8B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Pensionmark Financial Group, LLC Portfolio

Follow Pensionmark Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pensionmark Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pensionmark Financial Group, LLC with notifications on news.